Solriamfetol Completed Phase 2 Trials for Obstructive Sleep Apnea (OSA) / Somnolence Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02806895Study Assessing Effects of JZP-110 on Driving Performance in the Treatment of Excessive Sleepiness in OSA